Prevalence of Subacromial Impingement Among Egyptian Swimmers

NCT05548816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 405

Last updated 2023-03-28

No results posted yet for this study

Summary

In the available literature, there are no prevalence studies that show the incidence of subacromial impingement in swimmers in Egypt, this should be considered as it's one of the most commonly reported injuries worldwide in swimmers. There are also no available studies to show the difference in incidence of subacromial impingement between both genders in Egypt. This study is attempting to remedy both research deficits and to reduce the literature gap and to show the prevalence rate of this injury among Egyptian swimmers in different age groups, to help prevent its widespread and to provide data for further investigations. This study would give the Egyptian swimming federation and the Ministry of youth and sports a clear idea about the prevalence rate of swimmer's shoulder at different ages in Egyptian swimmers. Most importantly, this study is to provide the physiotherapy community in Egypt data about this injury, the rate of prevalence and how to prevent it and hopefully would help in further future studies and also to apply it in different countries.

Conditions

  • Subacromial Impingement Syndrome

Interventions

OTHER

Handheld Dynamometer , Special tests and Modified DASH questionarre .

A mix of tools , special tests and questionarre to help in confirming the diagnosis of subacromial impingement.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-30
Primary Completion
2022-12-31
Completion
2023-01-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05548816 on ClinicalTrials.gov